Jeff delves into the groundbreaking concept of immune checkpoint blockade in cancer treatment, explaining how targeting the T cell off switch revolutionized long-term patient survival rates. The discovery of this approach in 2011 marked a significant milestone in cancer immunotherapy, offering hope for durable responses to cancer treatment.
